We recently proposed that the mechanism present in breast cancer, where hormone-dependent estrogen receptor (ER)-mediated Hippo and YAP/TAZ regulation occurs, might be conserved in PCa via AR (Salem & Hansen, 2019). Here, YAP1 is linked to breast cancer.